Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autogenic Drainage in Cystic Fibrosis
NCT03655249Withdrawn
- Start
- Aug 2018
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Randomised, open-label trial in cystic fibrosis (CF) (2 arms). Primary endpoint: Change in Lung Clearance Index up to 2 weeks. Planned start Aug 2018; status: withdrawn.
02
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT03655249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03655249.